Treatment with the antioxidant metal-alloy nanozyme reduced the build-up (aggregation) and transmission of disease-causing alpha-synuclein protein in the nerve cells and brains of a Parkinson’s disease mouse model, a study reported. Investigators believe these findings support further research to evaluate nanozymes as a Parkinson’s treatment. The study, “Nanozyme scavenging ROS for prevention of pathologic α-synuclein transmission in Parkinson’s disease,” was published in the journal Nano Today.  Parkinson’s disease is characterized by the build-up of alpha-synuclein protein…

You must be logged in to read/download the full post.